FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...